Poland· PL-100342051
Orinox
A xylometazoline product containing xylometazolini hydrochloridum, registered in Poland by Dr. Max Pharma s.r.o.. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Xylometazoline is registered in 14 of 19 countries.
Countries holding a registration under ATC R01AA07 (xylometazoline), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Xylometazoline · ATC R01AA07
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Xylometazolini hydrochloridum
- Manufacturer
- Dr. Max Pharma s.r.o.
- Country
- Poland (PL)
- ATC code
- R01AA07
- ATC class
- Xylometazoline
- Defined daily dose
- 0.8 mg, N
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991288754
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for xylometazoline.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Xylometazoline · interactions on record
63 records
- 6 severe
- 54 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
- MethysergideN02CA04severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Xylometazoline in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAlbert Heijn Kinderneusspray Xylometazoline HCl 0,5 mg/ml, neusspray, oplossingHealthypharm B.V.
- SwedenNasoferm 0,5 mg/ml Nässpray, lösningNordic Drugs AB
- FinlandNaso-ratiopharmratiopharm GmbH
- BelgiumNasasinuspray Junior sine conservans Tegen neusverstopping 0.5 mg/mlKenvue Belgium
- NorwayOtrivinHaleon Denmark ApS
- IcelandOtrivin Junior ukonserveretHaleon Denmark ApS
- GermanyHysan SchnupfensprayUrsapharm Arzneimittel Gmbh
- SwitzerlandLIVSANE Junior Schnupfen Xylo 0.05 %, Nasenspray, LösungPharmapost AG
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Easynasan, Easynasan Junior
- Belgium · Nasa Rhinathiol, Nasasinuspray Abschwellend
- Bulgaria · Ксилогел, Ксилометазолин Wzf
- Cyprus · Hexarhinal, Nasoxyl
- Czechia · Mar Rhino, Nasenspray
- Germany · Hysan Schnupfenspray, Hysan Schnupfenspray Kinder
- Denmark · Klarigen, Otrivin Junior Ukonserveret
- Estonia · Galazolin, Mindea
- Spain · Amidrin, Idasal
- Finland · Nasment, Naso
- United Kingdom (Northern Ireland) · Clear Nose Spray, Nasoclear Decongestant
- Greece · Hexarhinal, Noselif
- Croatia · Meralys, Meralys Duo
- Hungary · Lolimarine Ha, Lolimarine Ha Kid
- Ireland · Otrivine Adult, Otrivine Adult Menthol
- Iceland · Nasogen Menthol, Nasogen Normal
- Italy · Actifed Decongestionante, Deltarindek Decongestionante
- Lithuania · Eucamidin, Galazolin
- Luxembourg · Nasa Rhinathiol, Nasasinuspray Décongestionnant
- Latvia · Galazolin, Ksilonex
- Malta · Hysan Adults, Hysan Paediatric
- Netherlands · Albert Heijn Menthol, Coldrex Xylosel
- Norway · Naso, Otrivin
- Portugal · Actifed Descongestionante Sem Conservantes, Nasex
- Romania · Bixtonim Xylo, Bixtonim Xylo Aroma
- Sweden · Nasoferm, Nasoferm Mentol
- Slovenia · Maresyl, Maresyl 0,5 Mg/Ml
- Slovakia · Mar Rhino, Olynth
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2b073859-a7dd-4a30-bd2c-73ebd98de753 GET /v1/drugs/2b073859-a7dd-4a30-bd2c-73ebd98de753?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol do nosa, roztwór",
"source": "urpl",
"strength": "0,5 mg/ml",
"packaging": "05909991288754 ¦ OTC ¦ 117112\n1 butelka 10 ml",
"substance": "Xylometazolini hydrochloridum 0,5 mg/ml",
"common_name": "Xylometazolini hydrochloridum",
"pl_product_id": "100342051",
"pozwolenie_nr": "23367",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about xylometazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.